IRIDEX Investor Relations Material

Iridex Corp is a developer, manufacturer, and supplier of ophthalmic therapeutic laser systems. The company offers its products that are used in the treatment of sight-threatening eye diseases in the ophthalmology market. It provides laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also offers VisionTherapy system consisting of TranscenDys universal laser attachable platform; integrated solution for surgical applications; iNext 3-fold zoomed excimer laser for non-pulse volume treatments; customizable wavelength based on a patient's exact requirement; launch from close up range without any disruption to contact lenses or intraocular lens implantation surgeries.